Certain proteins, such as inflammatory
cytokines, that are released
from injured or diseased organs are transported from the circulating
blood through the blood–brain barrier (BBB) into the brain
and contribute to the pathogenesis of related central nervous system
dysfunctions. However, little is known about the protein transport
mechanisms involved in the central nervous system dysfunctions. The
aims of the present study were to identify BBB-permeable protein(s)
derived from liver and to clarify their transport characteristics
at the BBB. After administration of biotin-labeled liver cytosolic
protein fraction to mice in vivo, we identified 9 biotin-labeled proteins
in the brain. Among them, we focused here on creatine kinase (CK).
In vitro uptake studies with human brain microvessel endothelial cells
(hCMEC/D3 cells) showed preferential uptake of muscle-type CK (CK-MM)
compared with brain-type CK (CK-BB) at the BBB. Integration plot analysis
revealed that CK-MM readily penetrated into brain parenchyma from
the circulating blood across the BBB. The uptake of CK-MM by hCMEC/D3
cells was decreased at 4 °C and in the presence of clathrin-
and caveolin-dependent endocytosis inhibitors. These results indicate
that entry of CK into the brain is mediated by a transport system(s)
at the BBB.